LIPOSORBER® LA-15 System
FDA premarket approval P910018/S038 · decided 2024-08-27
Approval details
- PMA number
- P910018
- Supplement
- S038
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- LIPOSORBER® LA-15 System
- Generic name
- Lipoprotein, low density, removal
- Applicant
- Kaneka Pharma America Corp.
- Date received
- 2024-07-29
- Decision date
- 2024-08-27
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- MMY
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- New York, NY
- Statement
- a change in the endotoxin testing device for LIPOSORBER LA-15
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.